SPIRIT Checklist of Protocol of Efficacy and safety of mizoribine in comparison with cyclophosphamide for treatment of lupus nephritis: a multi-center, open-label, randomized controlled trial

This is a completed SPIRIT checklist of the protocol. Protocol of Efficacy and safety of mizoribine in comparison with cyclophosphamide for treatment of lupus nephritis: a multi-center, open-label, randomized controlled trial have fully adhered to the SPIRIT reporting guidelines.

本研究方案已完成SPIRIT检查表。本项旨在比较咪唑立宾（Mizoribine）与环磷酰胺（Cyclophosphamide）治疗狼疮性肾炎（Lupus Nephritis）的多中心、开放标签、随机对照试验，其研究方案完全遵循SPIRIT报告指南。